Literature DB >> 11179379

Expression of cytolethal distending toxin and hemolysin is not required for pustule formation by Haemophilus ducreyi in human volunteers.

R S Young1, K R Fortney, V Gelfanova, C L Phillips, B P Katz, A F Hood, J L Latimer, R S Munson, E J Hansen, S M Spinola.   

Abstract

Haemophilus ducreyi makes cytolethal distending toxin (CDT) and hemolysin. In a previous human challenge trial, an isogenic hemolysin-deficient mutant caused pustules with a rate similar to that of its parent. To test whether CDT was required for pustule formation, six human subjects were inoculated with a CDT mutant and parent at multiple sites. The pustule formation rates were similar at both parent and mutant sites. A CDT and hemolysin double mutant was constructed and tested in five additional subjects. The pustule formation rates were similar for the parent and double mutant. These results indicate that neither the expression of CDT, nor that of hemolysin, nor both are required for pustule formation by H. ducreyi in humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179379      PMCID: PMC98108          DOI: 10.1128/IAI.69.3.1938-1942.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Experimental human infection with Haemophilus ducreyi.

Authors:  S M Spinola; L M Wild; M A Apicella; A A Gaspari; A A Campagnari
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

2.  An outbreak of chancroid in Orange County, California: descriptive epidemiology and disease-control measures.

Authors:  C A Blackmore; K Limpakarnjanarat; J G Rigau-Pérez; W L Albritton; J R Greenwood
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

3.  DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest.

Authors:  C A Elwell; L A Dreyfus
Journal:  Mol Microbiol       Date:  2000-08       Impact factor: 3.501

4.  An isogenic hemoglobin receptor-deficient mutant of Haemophilus ducreyi is attenuated in the human model of experimental infection.

Authors:  J A Al-Tawfiq; K R Fortney; B P Katz; A F Hood; C Elkins; S M Spinola
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

5.  DsrA-deficient mutant of Haemophilus ducreyi is impaired in its ability to infect human volunteers.

Authors:  C T Bong; R E Throm; K R Fortney; B P Katz; A F Hood; C Elkins; S M Spinola
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

6.  Characterization of the hemolytic activity of Haemophilus ducreyi.

Authors:  P A Totten; D V Norn; W E Stamm
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

7.  Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North America.

Authors:  G W Hammond; M Slutchuk; J Scatliff; E Sherman; J C Wilt; A R Ronald
Journal:  Rev Infect Dis       Date:  1980 Nov-Dec

8.  Identification of a hemolytic activity elaborated by Haemophilus ducreyi.

Authors:  K L Palmer; S Grass; R S Munson
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

Review 9.  Chancroid and Haemophilus ducreyi.

Authors:  S A Morse
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

10.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  25 in total

1.  Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains extracellular throughout infection of human volunteers.

Authors:  M E Bauer; M P Goheen; C A Townsend; S M Spinola
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Transcription of candidate virulence genes of Haemophilus ducreyi during infection of human volunteers.

Authors:  R E Throm; S M Spinola
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 3.  Immunopathogenesis of Haemophilus ducreyi infection (chancroid).

Authors:  Stanley M Spinola; Margaret E Bauer; Robert S Munson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Expression of the cytolethal distending toxin in a geographically diverse collection of Haemophilus ducreyi clinical isolates.

Authors:  K Kulkarni; D A Lewis; C A Ison
Journal:  Sex Transm Infect       Date:  2003-08       Impact factor: 3.519

5.  Transferable antibiotic resistance elements in Haemophilus influenzae share a common evolutionary origin with a diverse family of syntenic genomic islands.

Authors:  Zaini Mohd-Zain; Sarah L Turner; Ana M Cerdeño-Tárraga; Andrew K Lilley; Thomas J Inzana; A Jane Duncan; Rosalind M Harding; Derek W Hood; Timothy E Peto; Derrick W Crook
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

6.  Haemophilus ducreyi infection induces activation of the NLRP3 inflammasome in nonpolarized but not in polarized human macrophages.

Authors:  Wei Li; Barry P Katz; Margaret E Bauer; Stanley M Spinola
Journal:  Infect Immun       Date:  2013-06-10       Impact factor: 3.441

7.  Role played by CD4+FOXP3+ regulatory T Cells in suppression of host responses to Haemophilus ducreyi during experimental infection of human volunteers.

Authors:  Wei Li; Klara Tenner-Racz; Paul Racz; Diane M Janowicz; Kate R Fortney; Barry P Katz; Stanley M Spinola
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

8.  Cytolethal distending toxin type I and type IV genes are framed with lambdoid prophage genes in extraintestinal pathogenic Escherichia coli.

Authors:  István Tóth; Jean-Philippe Nougayrède; Ulrich Dobrindt; Terence Neil Ledger; Michèle Boury; Stefano Morabito; Tamaki Fujiwara; Motoyuki Sugai; Jörg Hacker; Eric Oswald
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

9.  Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae.

Authors:  Patricia L Winokur; Kathryn Chaloner; Gary V Doern; Jennifer Ferreira; Michael A Apicella
Journal:  J Infect Dis       Date:  2013-05-28       Impact factor: 5.226

10.  In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants.

Authors:  Vincent B Young; Kimberly A Knox; Jason S Pratt; Jennifer S Cortez; Linda S Mansfield; Arlin B Rogers; James G Fox; David B Schauer
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.